Panama's Supreme Court has annulled the long-term concession of Hong Kong-based CK Hutchison to operate key ports at the Panama Canal, appointing Denmark's Maersk as temporary administrator. The move follows geopolitical tensions and allegations of unpaid fees.
As gold prices soar past $5,400 an ounce before a sharp pullback, a global rush is underway. From Parisian boutiques to Main Street dealers, consumers are capitalizing on heirlooms or diving into the market, driven by geopolitical tensions and economic uncertainty.
A new Morgan Stanley report indicates Amazon is in early discussions with select shippers about its planned Less-Than-Truckload service, set to launch this summer, posing a potential long-term challenge to established carriers.
Salesforce secures a potential 10-year, $5.6 billion IDIQ contract with the U.S. Army, a strategic win for its national security unit. Yet, analysts caution the headline figure is a ceiling, not a guarantee, with real value hinging on future task orders and AI integration.
Elon Musk is reportedly in discussions to merge his aerospace giant SpaceX with his artificial intelligence venture xAI, aiming to create an integrated powerhouse for deploying AI data centers in orbit, powered by space solar energy.
The doughnut giant has agreed to a multimillion-dollar settlement following a 2024 cyberattack that compromised personal data of current and former staff, though it admits no fault.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.
In a significant policy shift, Chinese authorities have reportedly cleared the AI startup DeepSeek to purchase Nvidia's advanced H200 processors, potentially easing a major hardware bottleneck for its competitive large language model.
President Trump's nomination of Kevin Warsh, a known monetary policy hawk, to lead the Federal Reserve sent initial shockwaves through equities and bonds on Friday, raising questions about the future path of interest rates.
The drive-thru coffee chain 7 Brew debuts a monthly rotating menu of featured beverages, starting with five options for February including a new Chocolate Dipped Strawberry Cold Brew, as it leverages its strong rewards membership to boost visit frequency.
Walmart is significantly expanding its electric vehicle charging infrastructure, with planned installations at select stores across 19 states, advancing its goal to build a nationwide network by 2030.
As SpaceX targets a record-shattering IPO for mid-2026, reports indicate Elon Musk is exploring a potential merger with either Tesla or his AI startup, xAI. The move could create a unified tech and industrial behemoth but faces significant regulatory and operational hurdles.
The iconic California-born chain Peet's Coffee is closing 27 locations, including outlets in Manhattan Beach and Redondo Beach, as it navigates post-acquisition restructuring and a challenging market for mid-size coffee retailers.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Shares of Allison Transmission Holdings (ALSN) have surged over 35% in three months, reigniting a fierce debate among analysts over whether the stock is overvalued or still trading at a deep discount to its future cash flows.
The FDA has cleared Intuitive Surgical's da Vinci 5 robotic system for select complex cardiac procedures, a move that could reshape the landscape of minimally invasive heart surgery and open a significant new market for the industry leader.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
The commencement of sea trials for the nuclear-powered aircraft carrier USS John F. Kennedy coincides with the 140th anniversary of its builder, Newport News Shipbuilding, underscoring Huntington Ingalls Industries' entrenched role in U.S. naval defense and its long-term investment profile.
